Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives

Area of Science:

• Oncology
• Nanotechnology
• Cell Biology

Background:

• Cancer cells often evade programmed cell death (apoptosis), a key mechanism targeted by conventional therapies.
• Tumor resistance to apoptosis-based treatments necessitates exploring alternative cell death pathways for effective cancer therapy.
• Engineered nanoparticles offer potential for targeting novel cell death mechanisms in cancer treatment.

Purpose of the Study:

• To review the potential of targeting nonapoptotic cell death pathways in cancer therapy.
• To explore the role of ferroptosis, autophagy, and necroptosis in overcoming apoptosis resistance.
• To highlight the application of nanotherapeutics in exploiting these alternative pathways.

Main Methods:

• Review of current research on nonapoptotic cell death pathways (ferroptosis, autophagy, necroptosis).
• Analysis of nanoparticle applications in targeting these pathways.
• Discussion of challenges and advancements in the field.

Main Results:

• Nonapoptotic pathways like ferroptosis, autophagy, and necroptosis are viable targets in apoptosis-defective tumors.
• Engineered nanoparticles show promise for delivering therapeutics to these alternative death pathways.
• Targeting these pathways presents a novel direction for cancer drug development and nanotherapeutics.

Conclusions:

• Targeting nonapoptotic cell death pathways is a promising strategy to overcome cancer therapy resistance.
• Nanotherapeutics can be exploited to selectively target ferroptosis, autophagy, and necroptosis.
• Further research into clinical merits of these approaches is warranted for future cancer treatment.